-9.6 C
New York
Monday, December 23, 2024

GLP-1 Medicine: FDA Removes Lilly’s Zepbound® and Mounjaro® (tirzepatide injection) from its Drug Scarcity Record


The put up GLP-1 Medicine: FDA Removes Lilly’s Zepbound® and Mounjaro® (tirzepatide injection) from its Drug Scarcity Record appeared first on Foley & Lardner LLP.

Related Articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest Articles